Page last updated: 2024-10-29

ketanserin and Hyperglycemia

ketanserin has been researched along with Hyperglycemia in 4 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Hyperglycemia: Abnormally high BLOOD GLUCOSE level.

Research Excerpts

ExcerptRelevanceReference
" Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia."3.75Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009)
"-induced hyperglycemia was strongly antagonized by the 5-HT2A receptor antagonist ketanserin."3.69The involvement of the peripheral 5-HT2A receptor in peripherally administered serotonin-induced hyperglycemia in rats. ( Horisaka, K; Kimura, I; Sugimoto, Y; Yamada, J; Yoshikawa, T, 1995)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shen, KP1
Lin, HL1
Hsieh, SL1
Kwan, AL1
Chen, IJ1
Wu, BN1
Yamada, J3
Sugimoto, Y3
Yoshikawa, T2
Kimura, I1
Horisaka, K1

Other Studies

4 other studies available for ketanserin and Hyperglycemia

ArticleYear
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:4

    Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut

2009
The involvement of the peripheral 5-HT2A receptor in peripherally administered serotonin-induced hyperglycemia in rats.
    Life sciences, 1995, Volume: 57, Issue:8

    Topics: Animals; Blood Glucose; Epinephrine; Hyperglycemia; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Re

1995
p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
    European journal of pharmacology, 1998, Oct-23, Volume: 359, Issue:2-3

    Topics: 4-Aminobenzoic Acid; Adrenal Medulla; Adrenalectomy; Aminopyridines; Animals; Blood Glucose; Dose-Re

1998
Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:12

    Topics: Adrenal Medulla; Amphetamines; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucagon; H

2000